Anti-ceramidase LCL385 acutely reduces BCL-2 expression in the hippocampus but is not associated with an increase of learned helplessness in rats

類似資料

• Anticancer actions of lysosomally targeted inhibitor, LCL521, of acid ceramidase.
  著者:: Aiping Bai, 等
  出版事項: (2017-01-01)
• Anticancer actions of lysosomally targeted inhibitor, LCL521, of acid ceramidase
  著者:: Bai, Aiping, 等
  出版事項: (2017)
• Dose Dependent Actions of LCL521 on Acid Ceramidase and Key Sphingolipid Metabolites.
  著者:: Bai, Aiping, 等
  出版事項: (2018)
• CATIONIC CERAMIDES AND ANALOGUES, LCL30 AND LCL85, AS ADJUVANTS TO PHOTODYNAMIC THERAPY OF TUMORS
  著者:: Korbelik, Mladen, 等
  出版事項: (2013)
• Downregulation of Neutral Ceramidase by Gemcitabine: Implications for Cell Cycle Regulation
  著者:: Wu, Bill X., 等
  出版事項: (2009)